Bupropion
Bupropion is an antidepressant that works in the brain to treat depression.
| Product dosage: 150mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.37 | $41.00 (0%) | 🛒 Add to cart |
| 60 | $1.07 | $82.00 $64.00 (22%) | 🛒 Add to cart |
| 90 | $0.97 | $123.00 $87.00 (29%) | 🛒 Add to cart |
| 120 | $0.93 | $164.00 $111.00 (32%) | 🛒 Add to cart |
| 180 | $0.87 | $246.00 $157.00 (36%) | 🛒 Add to cart |
| 270 | $0.84 | $369.00 $227.00 (38%) | 🛒 Add to cart |
| 360 | $0.82
Best per pill | $492.00 $297.00 (40%) | 🛒 Add to cart |
Similar products
More info:
Contrave: A Clinically Proven Weight Management Medication
Contrave is a prescription medication approved by the FDA for chronic weight management in adults. It combines two active ingredients, naltrexone HCl and bupropion HCl, in an extended-release formulation designed to work on areas of the brain involved in appetite control and reward. This dual-action approach helps reduce hunger and cravings, supporting sustainable weight loss when used alongside a reduced-calorie diet and increased physical activity. It is indicated for use in adults with an initial body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater in the presence of at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia.
Mysimba: A Clinically Validated Adjunct for Sustainable Weight Management
Mysimba (naltrexone HCl and bupropion HCl) extended-release tablets represent a significant advancement in the pharmacological management of chronic weight management in adults. This combination product is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m² or greater (obesity), or 27 kg/m² or greater (overweight) in the presence of at least one weight-related comorbidity such as hypertension, type 2 diabetes mellitus, or dyslipidemia.
Acamprol: Restoring Neurochemical Balance for Alcohol Dependence Management
Acamprol (acamprosate calcium) is a clinically validated pharmacotherapy specifically formulated to support abstinence maintenance in alcohol-dependent patients following detoxification. As a synthetic compound with structural similarity to endogenous neurotransmitters, it modulates glutamatergic hyperactivity and GABAergic hypoactivity associated with chronic alcohol exposure. Its targeted mechanism addresses the neuroadaptations underlying craving and withdrawal, offering a physiological foundation for sustained recovery. Acamprol represents an essential component of comprehensive treatment programs when combined with psychosocial interventions.
Accufine: Precision-Engineered Relief for Chronic Neuropathic Pain
Accufine represents a significant advancement in the pharmacological management of moderate to severe chronic neuropathic pain. This prescription medication, containing the active ingredient Pregabalin, is specifically formulated to modulate hyperexcited neurons, targeting the underlying pathophysiology of nerve pain rather than merely masking symptoms. Its development is grounded in extensive clinical research, offering a targeted therapeutic option for patients who have found inadequate relief from conventional analgesics. By binding to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, Accufine reduces the release of several neurotransmitters, thereby decreasing neuronal excitability and providing sustained, reliable pain control.
Accutane: The Definitive Solution for Severe Nodular Acne
Accutane (isotretinoin) is a potent oral retinoid medication specifically formulated for treatment-resistant, severe nodular acne that has proven unresponsive to conventional therapies. As a derivative of vitamin A, it operates through a multi-mechanistic approach targeting the fundamental pathological drivers of acne vulgaris. This prescription-only medication represents the most clinically effective intervention available for recalcitrant cystic acne, offering potential long-term remission where other treatments have failed. Strict medical supervision is mandatory throughout the course of therapy due to its significant teratogenic potential and possible serious adverse effects.
Aciclovir: Effective Antiviral Treatment for Herpes Infections
Aciclovir is a nucleoside analogue antiviral medication specifically designed to manage infections caused by the herpes simplex virus (HSV) and varicella-zoster virus (VZV). As a first-line therapeutic agent, it inhibits viral DNA replication, thereby reducing the severity and duration of outbreaks. Clinically proven and widely prescribed, aciclovir is available in oral, topical, and intravenous formulations to suit varying patient needs and clinical scenarios. Its mechanism of action targets infected cells while sparing healthy ones, offering a favorable safety profile for both episodic treatment and long-term suppressive therapy.
Aciphex: Advanced Acid Control for GERD Relief
Aciphex (rabeprazole sodium) is a proton pump inhibitor (PPI) designed for the effective, long-term management of gastroesophageal reflux disease (GERD) and associated conditions. By targeting the proton pumps in the stomach lining, it provides sustained reduction of gastric acid production, facilitating mucosal healing and symptom relief. This prescription medication is formulated for patients requiring consistent acid suppression, offering a clinically proven option for both short-term symptomatic control and maintenance therapy in moderate to severe cases.
Acivir Pills: Effective Antiviral Treatment for Herpes Infections
Acivir Pills contain the active ingredient acyclovir, a nucleoside analogue DNA polymerase inhibitor specifically designed to combat herpesvirus infections. This oral formulation is a cornerstone in the management of both initial and recurrent episodes of herpes simplex and herpes zoster. By inhibiting viral replication, Acivir reduces the duration of symptoms, accelerates healing, and decreases the risk of transmission. It is a well-established antiviral medication backed by extensive clinical evidence and is commonly prescribed by healthcare professionals for its efficacy and favorable safety profile.
Acticin: Effective Topical Permethrin Treatment for Scabies
Acticin is a prescription topical medication containing permethrin, a synthetic pyrethroid widely recognized for its potent scabicidal and pediculicidal properties. It is formulated as a cream for cutaneous application, specifically indicated for the eradication of Sarcoptes scabiei mites and their eggs. This medication works through neurotoxic action on the parasite’s nervous system, leading to paralysis and death, while exhibiting low mammalian toxicity. Clinical efficacy is well-documented, making it a first-line treatment in numerous dermatological guidelines worldwide.